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The two hypoxia-inducible factors (HIF-1a and HIF-2a) are
transcription factors that regulate the response to hypoxia.
Recently, the factor inhibiting HIF (FIH1) was identified as
a molecular oxygen-dependent dioxygenase that blunts the
transcriptional activity of HIF and has also been implicated
in HIF-dependent and -independent hypoxia responses.
Interestingly, HIF accumulation in the kidney has been shown
to confer renal protection and to also cause glomerular injury
or enhance renal fibrosis. In order to better understand the
regulation of hypoxia-inducible genes, we determined the
expression of FIH1 in the kidney and its functional role in
isolated renal cells. FIH1 was expressed only in distal tubules
and in podocytes, thus showing a very distinct expression
pattern, partially overlapping with sites of HIF-1a expression.
In tubular cells, RNA silencing of FIH1 caused transcriptional
activation of HIF target genes during hypoxia. In contrast,
FIH1 silencing in podocytes enhanced transcription of
hypoxia-inducible genes in an HIF-independent manner.
Using the anti-Thy.1 rat model of glomerulonephritis, we
found a gradual decrease of glomerular FIH1 expression
during disease progression paralleled by an increase in
hypoxia-inducible genes including CXCR4, a mediator of
glomerular inflammation. Thus, FIH1 appears to be a
suppressor of oxygen-dependent genes in the kidney,
operating through HIF-dependent and -independent
mechanisms.
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Many aspects of kidney function under physiological and
pathophysiological conditions are closely related to the
prevailing oxygen tension in the kidney. To adapt to hypoxia
and to prevent ischemic injury, counter-regulatory mechan-
isms have evolved in the kidney, which are in part mediated
by the two hypoxia-inducible transcription factors (HIF-1a
and HIF-2a), which are stabilized under low oxygen tensions.
HIF can initiate transcription of more than 100 genes, which
are involved, for example, in glycolysis, angiogenesis,
erythropoiesis, and cell cycle regulation or cell survival. In
the kidney, HIF-1a has been localized to the tubular epithelia,
whereas HIF-2a is predominantly located in endothelial,
glomerular, and interstitial cells.1 Concordantly, HIF-2a
appears to be the HIF isoform controlling erythropoietin
production in peritubular interstitial cells.2,3 In the presence
of oxygen, two proline residues within the oxygen-dependent
degradation domain of the a-chain of the HIF protein
are hydroxylated by at least three prolyl hydroxylase
domain (PHD1–3) proteins. Hydroxylation of HIF leads to
ubiquitination by the pVHL (von Hippel–Lindau protein)
ubiquitin ligase, which targets HIF-a for proteasomal
degradation. When molecular oxygen is not available for
hydroxylation, HIF can accumulate in the cell and can
promote transcription of its target genes (for review, see
Kaelin and Ratcliffe4).
We and others have shown that induction of HIF through
hypoxia or inhibition of HIF PHDs protects the kidney
against ischemic or toxic injury.5–10 On the other hand,
knockout of the VHL protein in podocytes, which interrupts
HIF degradation, was found to induce glomerular injury,
resembling human pauci-immune rapid progressive glomer-
ulonephitis.11 In addition, VHL knockout in tubular cells was
associated with accelerated tubulointerstitial fibrosis.12,13
Although VHL knockdown has effects beyond HIF stabiliza-
tion, these data may suggest that HIF-dependent gene
expression can have both beneficial and detrimental effects
and therefore needs to be tightly controlled.
Another hydroxylase, which has been identified to control
transcription of HIF target genes, is factor inhibiting HIF
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(FIH1), which hydroxylates the asparagine residue 803 of the
N-terminal transactivation domain of HIF1-a. FIH1 inhibits
binding of the co-activator p300 to the HIF protein, which is
necessary to initiate gene transcription.14–16 FIH1 knockdown
in human cell lines showed that FIH1 suppression signifi-
cantly enhances transcription of HIF target genes in a wide
range of decreasing oxygen tensions, but not in anoxia,
implicating a high oxygen affinity and a wide range of HIF
transcriptional control.17 Moreover, there is experimental
evidence that FIH1 not only controls HIF transcription, but
also targets other regulatory pathways such as Ik-Ba, Notch,
or MYPT1 by oxygen-dependent asparagine hydroxylation of
ankyrin repeat domains.18–20 The functional role of this
interaction is not fully understood, but may point to a
common oxygen-dependent pathway regulating cell
adaptation through HIF-dependent and HIF-independent
mechanisms.
As the expression and functional role of FIH1 in the
kidney have not been studied so far, we determined FIH1
expression and regulation in the kidney and isolated renal
cells to determine its role in the transcriptional response
to hypoxia.
RESULTS
FIH1 is expressed in a variety of organs, but has a specific
expression pattern in human and rodent kidneys
To test for the occurrence of FIH1 in different organs, we first
examined different tissues from normoxic and hypoxic rats
and mice and screened for FIH1 mRNA and protein
expression. All organs investigated expressed FIH1 mRNA,
with highest levels in the rat and mouse heart (Figure 1a,
mouse data not shown).
To specify antibody selectivity, we used rat kidney protein
lysates from normoxic and hypoxic rats. The used antibody
(Novus Biologicals, Littleton, CO, USA) detected a single
band at the predicted molecular weight of FIH1 (B40 kDa)
(Figure 1b). There was no effect of systemic hypoxia on FIH1
protein expression.
Using this antibody for immunohistochemistry, FIH1
protein in the heart and in the liver was primarily found in
cardiomyocytes and hepatocytes, respectively, with a uniform
expression pattern. In the brain we found FIH1 in neurons,
confirming a previously published study by Fukuba et al.21
(Figure 1c). In contrast, in kidneys from rodents and
humans, FIH1 protein showed a very distinct expression
pattern (Figure 1d). FIH1 was expressed in the cytoplasm of
some, apparently distal tubules and glomerular cells. No
staining was observed in interstitial cells.
Similar results in immunohistochemistry were obtained
using a second anti-FIH1 antibody (Santa Cruz Biotechno-
logy, Santa Cruz, CA, USA). FIH1 staining was prevented by
preincubation of the slides with a specific blocking peptide
(Novus Biologicals, data not shown), confirming specifity. In
line with in vitro analyses,17 we could not determine an effect
of hypoxia on FIH1 mRNA or protein expression in all tissues
of mice and rats examined (Figure 1b and data not shown).
FIH1 colocalizes with markers for distal tubules and
podocytes
To further specify the sites of FIH1 expression in tubular and
glomerular cells in more detail, we used cell-specific markers
for immunohistochemistry on serial sections of the rat
kidney. In addition, immunelectron microscopy was
employed to define glomerular and tubular FIH1 expression.
FIH1 protein in tubular cells was predominantly found in
the thick ascending limb, distal convoluted tubules, and
collecting ducts, which stained positive for Tamm–Horsfall
protein, sodium chloride cotransporter, and b-hydroxys-
teroid dehydrogenase, respectively (Figure 2). In collecting
ducts, both principal and intercalated cells were positive for
FIH1 (data not shown). No FIH1 protein was found in
proximal tubular cells identified by sodium phosphate
cotransporter IIa staining.
In the glomeruli, FIH1 colocalized with synaptopodin,
indicating expression in podocytes (Figure 3a). FIH1 protein
was not detectable in endothelial cells (Figure 3a). A
corresponding glomerular expression pattern for FIH1 was
seen in the mouse kidney (data not shown).
These results were confirmed by electron microscopy
using immunogold labeling of FIH1, which showed FIH1
predominantly in the cytoplasm of podocytes. In addition,
FIH1 immunogold signals were diffusely scattered in the
cellular cytoplasm of distal tubular cells (Figure 3b).
FIH1 mRNA expression in different nephron segments
matches the results of immunohistochemistry
In order to determine whether selective detection of FIH1
protein in some nephron segments (Figure 4a) was due to
differences in mRNA expression, we performed real-time
PCR analyses of mRNA from microdissected rat nephron
segments. As shown in Figure 4b and c, the results completely
matched the results from immunohistochemistry. In distal
nephron segments (TAL, DCT, CD) two- to sixfold higher
expression levels of FIH1 mRNA were measured as compared
with glomerular FIH1 expression.
FIH1 colocalizes with HIF-1a in tubular cells
Because FIH1 is primarily associated with HIF-1a and
HIF-2a transcriptional control, we assessed a possible
colocalisation of FIH1 with the HIFa chains. As described
previously, HIF-2a is predominantly expressed in endothelial
cells and interstitial fibroblasts in the rat kidney, and as
shown in the previous experiments, FIH1 was not expressed
in either of these cell types. We therefore focused on HIF-1a
expression and found an overlap of FIH1 and HIF-1a
expression predominantly in distal tubules of the hypoxic rat
kidney (Figure 4d).
In human tubular cells FIH1 knockdown modulates hypoxic
gene expression
To further characterise a possible functional role of FIH1 in
tubular cells we used the human kidney cell line HKC-8 and
performed FIH1 knockdown experiments. After 48 h small
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interfering RNA (siRNA) transfection, FIH1 mRNA levels
were reduced by approximately 80% (on average 83% in
normoxia and 79% in hypoxia). HIF-1a protein levels were
significantly enhanced under hypoxic conditions, but FIH1
knockdown had no significant effect on HIF-1a protein
(Figure 5a). To test for a regulatory role of FIH1 in HIF-
controlled gene regulation, we analyzed transcript levels of
the known HIF target genes GLUT1, PHD3, VEGF (vascular
endothelial growth factor), CXCR4, and TGFb1 (transform-
ing growth factor-b1), which have defined roles in different
aspects of HIF-dependent functions, including anaerobic
glycolysis, angiogenesis, inflammation, and fibrosis. These
genes were induced 1.7- to 11.8-fold by hypoxia (Figure 5b).
Under ambient oxygen levels, FIH1 knockdown led to no
changes in mRNA expression levels of these genes, pre-
sumably because the three PHDs are active in the presence of
oxygen and thereby mediate HIF degradation. In contrast,
under hypoxia, FIH1 knockdown of HKC-8 cells led to an
increase of mRNA levels of three target gene transcripts
(GLUT1, PHD3, and VEGF) as compared with the hypoxic
controls without FIH1 knockdown (Figure 5c). These
findings indicate that FIH1 hydroxylation was still active at
1% oxygen in tissue culture and still inhibited HIF target
gene transcription. Changes of target gene expression were
confirmed in western blot experiments for GLUT1 and PHD3
(Figure 5a).
In human podocytes FIH1 knockdown modulates normoxic
gene expression
To check the role of FIH1 in podocytes, we used a
temperature-sensitive human podocyte cell line22 and con-
ducted FIH1 knockdown experiments. After 16 h exposure to
1% oxygen, HIF-1a and -2a markedly accumulated in
immunoblots (Figure 6a). To test for a role of FIH1 in
HIF-controlled gene regulation, we analyzed the same five
HIF target genes tested in the tubular cell line (Figure 6b).11
VEGF, GLUT1, and TGFb1 were induced by hypoxia about
1.5- to 2-fold. CXCR4, which has previously been shown to
be important for podocyte physiology, and PHD3 showed
markedly higher amplitudes of induction (7.8±4.2-
and 17.1±14.3-fold). Knockdown of FIH1 in the podocyte
cell line under 21% O2 led to a 70% reduction of FIH1
mRNA and protein levels. Under normoxia, in contrast
to the tubular cell line HKC8, FIH1 knockdown induced
mRNA expression levels of CXCR4 and to a lesser extent of
VEGF and TGFb1 in the absence of detectable levels of
HIF protein. Apart from a small increase in PHD3 transcript,
siRNA-mediated silencing of FIH1 in hypoxia had no
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Figure 1 | Tissue distribution of factor inhibiting hypoxia-inducible factor-1 (FIH1) in the rat and FIH1 expression in rat, mouse, and
human kidney cortex. (a) Expression of factor inhibiting hypoxia-inducible factor-1 (FIH1) mRNA in different rat organs, assessed by RNAse
protection assay, N, normoxia; H, hypoxia. snRNA (small nuclear RNA) was used as a loading control. (b) Western blot analyses of whole
kidney lysates from two rats kept under ambient oxygen (1, 2) and from two rats kept in 8% O2 for 6 h (3, 4) using the rabbit anti-FIH1
antibody employed in the immunohistochemical experiments. A specific protein band for FIH1 was seen atB43 kDa. There was no hypoxic
regulation of FIH1 protein in whole kidney lysates. (c) Immunohistochemistry for FIH1 protein in different rat organs, Bar¼ 50 mm.
(d) Comparative immunohistochemical staining of FIH1 in rat, mouse, and human kidney cortex using a rabbit anti-FIH1 primary antibody
and 3,30 diaminobenzidine as chromogen.
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effect on the expression of these genes. We also tested
transcript levels of VHL, the ubiquitin ligase important for
HIF degradation, and found no change in expression levels
under the above-mentioned conditions (data not shown).
FIH1 expression in a rodent model of glomerular disease
To test the possible relevance of FIH1 in podocytes, we
induced experimental glomerulonephritis in the rat using a
single injection of anti-Thy.1 antibody OX7. Animals (four
per time point) were followed up for 3, 5, 8, or 12 days.
Proteinuria showed a significant increase over the whole
follow-up period indicating the onset of glomerular damage
(Figure 7a). At each time point, glomeruli were isolated from
rat kidneys and tissue samples were collected for mRNA
and protein analysis. FIH1 mRNA was significantly reduced
by 30% (Po0.05) compared with controls at day 3 after
injection of the anti-Thy.1 antibody. In immunohisto-
chemistry, FIH1 signals gradually decreased during the study
period (Figure 7b). Eventually, at 12 days we saw a significant
decrease of FIH1 immunoreactivity in the diseased glomeruli
and only weak FIH signals remained, in contrast to strong
podocyte signals in control slides. To further test transcrip-
tion levels of the five HIF target genes, which were previously
investigated in the knockdown experiments, we analyzed
RNA samples from isolated glomeruli in the course of
anti-Thy.1 nephritis. Additionally, we analyzed transgelin
mRNA as a positive control, because transgelin has been
described to be upregulated in experimental glomerulone-
phritis.23,24 During the time course of the anti-Thy.1
nephritis, we found a marked increase in transgelin and
CXCR4 transcripts at days 3–5. TGFb1 showed a small but
consistent upregulation over time, which is in agreement
with former studies.24 GLUT1 and PHD3 were reduced to
about 50% at days 3 and 5 (PHD3) or day 12 (GLUT1),
respectively (data not shown).
DISCUSSION
This study identifies FIH1 as a potentially important
repressor of the expression of hypoxia-inducible genes in
the kidney. In contrast to other organs, including the brain,
heart, and liver, FIH1 expression in the kidney was found to
be limited to two cell types: distal tubular cells and
podocytes. In distal tubular cells, FIH1 protein colocalized
well with the HIF PHD1–325 and hypoxic HIF-1a protein
accumulation. In particular, PHD2 has been identified to be
the key regulatory hydroxylase, which controls cellular HIF
levels in knockdown26 and knockout studies.27 The coin-
cidence of PHD2, HIF-1a, and FIH1 in distal tubular cells
implicates a synergistic regulatory control for cellular HIF
accumulation and gene transcription. However, the tubular
expression pattern of FIH1 overlaps, but does not completely
match to HIF-1a expression in the kidney, as proximal
tubules, which lack FIH1 signals, also accumulate HIF-1a
under hypoxia, albeit to a lesser extend compared with some
distal tubular segments.1 In concert with FIH1, no significant
PHD2 protein levels were detected in proximal tubules
either,25 which implicates differences in HIF-1a control in
this tubular segment.
Of note, peritubular cortical interstitial cells, which
express HIF-2a1 and synthesize erythropoietin,28,29 were
not found to stain for FIH1, indicating that this inhibitory
mechanism of HIF-dependent gene transcription may not be
relevant for the control of renal erythropoietin synthesis.
HIF-2 accumulation also occurs in glomerular cells, but these
cells appear to be endothelial cells rather than podocytes,1 so
that the expression of FIH1 in podocytes does not overlap
with HIF-2 accumulation in vivo.
Using immunelectron microscopy, we were able to
confirm the expression of FIH1 in podocytes and distal
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Figure 2 |Colocalization studies of factor inhibiting hypoxia-
inducible factor (HIF)-1 (FIH1) expression with cell-specific
markers of renal tubules in the rat kidney. Colocalization of
factor inhibiting hypoxia-inducible factor-1 (FIH1) (right panels)
with markers for different nephron segments (left panels) in serial
sections of the cortex from rat kidneys. FIH1 was predominantly
expressed in distal nephron segments as shown by colocalization
with Tamm–Horsfall protein (THP, thick ascending limb), NaCl
cotransporter (NCC, distal convoluted tubule), and 11(b)-
hydroxysteroid dehydrogenase (b-HSD, distal convoluted tubule
and collecting duct). FIH1 protein was not detectable in proximal
tubules, which stained positive for the sodium phosphate
cotransporter IIa (NaPi IIa). Arrows mark corresponding regions of
consecutive sections. Bar¼ 50 mm.
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tubular cells and found that the enzyme is consistently
located in the cytoplasm. HIF can shuttle into the nucleus
through nuclear pores30 and the PHDs were previously found
to be expressed either in the cytoplasm only (PHD2), the
cytoplasm and the nucleus (PHD3), or only in the nucleus
(PHD1), indicating that targeting of HIF for proteasomal
FIH1
FIH1
Synaptopodin Merge
MergeRECA-1
Nucleus
Nucleus
Nucleus
Ery
Figure 3 |Detection of factor inhibiting hypoxia-inducible factor (HIF)-1 (FIH1) in podocytes using fluorescence and
immunoelectron microscopy. (a) Factor inhibiting hypoxia-inducible factor-1 (FIH1) protein was detected in rat glomeruli, where it
colocalized with synaptopodin as marker for podocytes (upper panel). No FIH1 expression was detected in glomerular or tubulointerstitial
endothelial cells, which stained positive for RECA-1 (lower panel). Arrows mark corresponding regions. (b) Immunogoldlabeling of FIH1
confirmed FIH1 protein expression in rat podocytes (top left, top right, and bottom left) and distal tubular cells (bottom right). No FIH1
signals were detectable in endothelial or mesangial cells. Intracellular signals were diffusely scattered in the cytoplasm.
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degradation can occur in either compartment. On the basis
of the cytoplasmic location of FIH1, inhibition of the binding
of the transcriptional co-activator p300 appears to be
determined by cytoplasmic oxygen availability only.
In general, HIF degradation initiated by PHD-mediated
hydroxylation and inhibition of HIF transcription mediated
by FIH1-dependent hydroxylation of the p300 binding site
guarantee that the expression of hypoxia-inducible genes is
silenced in the presence of oxygen.15,16 FIH1 can thus be
considered as a safeguard mechanism to inhibit transcrip-
tional activity of HIF that has escaped proteasomal degrada-
tion. In addition, the oxygen dependency of PHDs and FIH1,
reflected by their Km values, may not be identical and some
data suggest that the oxygen affinity of FIH1 is higher than
that of the PHDs.17,31 This implies that with decreasing
oxygen concentrations PHDs may already be inactive,
resulting in HIF protein stabilization, while FIH1 can still
inhibit HIF transcriptional activity.
In order to study the functional role of FIH1 in the kidney,
we employed cell cultures of two cell types expressing FIH1
in vivo: HKC-8 cells derived from human tubules and
immortalized podocytes. A comparative analysis of FIH1
inhibition in both cell types revealed that the interaction
between FIH1 and HIF was different. Consistent with the
concept of complimentary effects of PHDs and FIH1 in
inhibiting HIF-dependent gene expression in the presence of
oxygen, FIH1 knockdown did not affect HIF target gene
mRNA levels in HKC-8 cells studied under ambient oxygen
conditions, that is, when HIF protein is absent. However,
when HIF protein was stabilized under hypoxic conditions,
FIH knockdown could further enhance HIF target gene
expression, revealing the transcriptional inhibition of HIF by
FIH1. On the contrary, augmentation of the hypoxic
induction of HIF target gene expression was not observed
in isolated podocytes. In comparison with the in vivo
situation, podocytes cultured in vitro were found to express
HIF-1a and HIF-2a in an oxygen-dependent manner, so that
the lack of effect of FIH1 inhibition cannot be explained by
insufficient HIF protein expression. It appears more likely
that under the given experimental conditions, FIH1 was
already completely inhibited by ‘hypoxia’ in podocytes, so
that its knockdown had no effect. Unexpectedly, augmenta-
tion of the expression of some HIF target genes (CXCR4 and
to a lesser extent VEGF and TGFb) was observed under
ambient air conditions. Under these conditions, HIF protein
was undetectable in immunoblots. Therefore, in order to
explain the enhanced expression of some HIF target genes
through increased transcriptional activity of HIF, one would
have to postulate that HIF levels below the detection limit
were functionally active. Alternatively, the observed effects
could be mediated by HIF-independent mechanisms of FIH1.
FIH1 has been proposed to have numerous other targets,
including, in particular, ankyrin repeat domains of proteins
such as p105 as a precursor of the p50 subunit of nuclear
factor-kB, Ik-Ba, or the notch receptor.18,19 The physiologi-
cal role of the ankyrin hydroxylation is presently not clear,
FIH1
FIH1 HIF-1α
FIH1
FIH1
Fo
ld
 e
xp
re
ss
io
n
*
*
Glo
m 
+
Glo
m 
-
PC
T
PS
T
dT
L TL
m
Ta
l
cTa
l
DC
T
CC
D
OM
CD
IM
CD
CCD
DCT
Glom
mTAL dTL Cortex
Outer medulla
Inner medulla
PST
PCT
OMCD
cTAL
IMCD
TL
8
7
6
5
4
3
2
1
0
Figure 4 | Factor inhibiting hypoxia-inducible factor (HIF)-1
(FIH1) mRNA expression along the rat nephron and
colocalization of FIH1 with HIF-a. (a) Higher-magnification
images of factor inhibiting hypoxia-inducible factor-1 (FIH1)
staining in the rat kidney showing specific FIH1 signals in
podocytes (left) and distal tubules (right). (b) Real-time PCR for
FIH1 mRNA expression in microdissected nephron segments of
the rat kidney. Results are expressed relative to FIH1 expression in
the glomeruli with adjacent arterioles (Glomþ ). Values are
means±s.d. of three different nephron segment preparations;
real-time PCR was carried out in duplicates. *Po0.05 as compared
with Glomþ . CCD, connecting and cortical collecting ducts; cTAL,
cortical thick ascending limbs; DCT, distal convoluted tubules;
dTL, descending thin limbs; Glomþ , glomeruli with arterioles;
Glom, glomeruli without arterioles; IMCD, inner medullary
collecting ducts; mTAL, medullary thick ascending limbs; OMCD,
outer medullary collecting ducts; PCT, proximal convoluted
tubules; PST, proximal straight tubules; TL, descending/ascending
limbs. (c) Schematic illustration depicting FIH1 expression along
the rat nephron. Expression 42-fold over glomerular expression
levels is indicated by bold lines. (d) Colocalization of HIF-1a and
FIH1 expression in tubules of the rat kidney cortex. HIF-1a was
stabilized by exposure of rats to 0.1% CO for 6 h. Bar¼ 50mm.
Arrows mark corresponding regions of consecutive sections.
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but it may substantially contribute to oxygen-dependent,
FIH1-mediated regulation of cell function.
Irrespective of the mechanism by which FIH1 represses
genes that are also HIF target genes in podocytes, in
particular, FIH1 mediated suppression of CXCR4 may be of
significant relevance. CXCR4 is a G-protein-coupled cytokine
receptor that binds stromal-derived factor. It has recently
been shown to have an important role in normal vascular
development in the kidney,32 but has also been postulated to
be relevant in podocyte-mediated injury.33 Ding et al.11
found that CXCR4 has an essential role in the development of
glomerulonephritis in animals with podocyte-specific knock-
out of VHL. Treatment of animals with a neutralizing CXCR4
antibody slowed disease progression in this model, whereas
overexpression of CXCR4 alone was sufficient to induce
podocyte proliferation.11 Intriguingly, in another established
model of acute glomerulonephritis, we found a significant
decrease of glomerular FIH-1 protein levels, which was
paralleled by an increase of CXCR4 expression. These
findings are consistent with the inhibition of CXCR4 gene
expression by FIH observed in vitro. Moreover, although
direct functional significance remains to be shown, these data
suggest that glomerular FIH expression has an important
anti-inflammatory role.
Taken together, our findings suggest an important role of
FIH1 as a suppressor of hypoxia-inducible genes in the
kidney, operating through HIF-dependent and HIF-indepen-
dent mechanisms.
MATERIALS AND METHODS
Reagents
Cell culture reagents were from Invitrogen (Karlsruhe, Germany)
and Biochrom (Berlin, Germany). Chemicals were from Sigma
(Taufkirchen, Germany), unless indicated otherwise.
Cell culture
HKC-8 cells were cultured in Dulbecco’s modified Eagle’s medium/
Ham’s F-12 supplemented with 10% fetal calf serum, 2 mmol/l
L-glutamine, 100 U/ml penicillin and 100mg/ml streptomycin,
5 mg/ml insulin, 5 mg/ml transferrin, and 5 ng/ml selenium. Differ-
entiated, growth-arrested podocytes were derived from podocytes,
which were conditionally transformed with a temperature-sensitive
mutant of SV-40 T antigen and were cultured as described
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Figure 5 | Effect of factor inhibiting hypoxia-inducible factor (HIF)-1 (FIH1) knockdown using FIH1 small interfering RNA (siRNA) in
human kidney cells (HKC-8) under room air and hypoxic conditions. (a) Immunoblots showing the effect of factor inhibiting
hypoxia-inducible factor (HIF)-1 (FIH1) knockdown (FIH1 small interfering RNA (siRNA)) on FIH1, HIF-1a, and HIF target gene protein levels in
human kidney cells (HKC-8) under ambient air or hypoxic conditions. Knockdown efficiency of FIH1 in HKC8 cells was on average about
80%. Knockdown of FIH1 led to a small increase of GLUT1 and to a more substantial increase of PHD3 protein. ctrl, control conditions
without transfection reagents; Luc, luciferase siRNA; mock, oligofectamine without siRNA; PHD, prolyl hydroxylase domain. (b) Fold
induction of HIF target genes by hypoxia compared with levels under ambient conditions. Values are means±s.d. of three independent
experiments. *Po0.05 as compared with control. (c) Effect of FIH1 knockdown using FIH1 siRNA on mRNA expression of the HIF-1a target
genes, VEGF, GLUT1, PHD3, CXCR4, and TGFb-1, as determined by real-time PCR. Under 21% O2 conditions (black bars) knockdown of FIH1
in HKC-8 led to no significant difference in HIF-1a target gene mRNA expression. Under hypoxic conditions (16 h, 1% oxygen, white bars)
gene expression of VEGF, GLUT1, and PHD3 was significantly enhanced under conditions of FIH1 knockdown. FIH1 mRNA was
downregulated by FIH1 siRNA under both 21% O2 and 1% O2. Values are means±s.d. of four independent experiments and normalized to
the corresponding luciferase siRNA control. *Po0.05 as compared with luciferase siRNA treatment.
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previously.22 Expression of markers of differentiation was checked
by western blotting for nephrin-1 and synaptopodin.
siRNA transfection
FIH1 siRNA was used for knockdown experiments as previously
described.17 siRNAs against firefly luciferase cloned into the pGL2
and the pGL3 vector, respectively (2luc sense siRNA 50-CGUACGCG
GAAUACUUCGAdTdT, 3luc sense 50CUUACGCUGAGUACUUCG
AdTdT) were used as controls. Apart from a modest reduction of
gene induction by the transfection procedure itself, we did not
observe any expression level differences using the luciferase siRNAs
when compared with untransfected cells. HKC-8 and podocytes
were grown in 10 cm dishes at a confluency of 30% and were
transfected with siRNAs (final concentration 40 nmol/l) by the use
of Oligofectamine (Invitrogen) in Optimem-1 medium, according
to the manufacturer’s protocol. For hypoxia experiments, cells were
exposed to 1% O2 for 16 h before harvesting.
Protein extraction and immunoblotting
Preparation of cell lysates and immunoblotting was performed as
described previously.34 Proteins were transferred onto polyvinyli-
dene difluoride membranes (Millipore, Schwalbach, Germay) and
probed with anti-FIH1 antibodies (Novus Biologicals or N-18,
Santa Cruz Biotechnology), PHD2 (Novus Biologicals), GLUT1 anti-
body (ABCAM, Cambridge, UK), HIF-1a antibody (Cayman
Chemical, Ann Arbor, MI, USA), mouse anti-PHD3 (a kind gift
from P. Ratcliffe, Oxford, UK) and anti-HIF-2a immune serum, as
described before34 or a b-actin antibody (Sigma).
RNA preparation, real-time PCR, and RNase protection assay
Total RNA from cell culture experiments or animal tissue was
extracted with RNAzol B (Biozol, Eching, Germany) according to
the manufacturer’s instructions. A quantity of 1 mg of total RNA was
reverse transcribed with murine leukemia virus reverse transcriptase
(Fermentas, St Leon-Rot, Germany). Real-time PCR was performed
using the SYBR-green method. Expression was measured on an ABI
Prism cycler, and data were analyzed using the DDCt method. HPRT
(hypoxanthine-guanine phosphoribosyltransferase) served as inter-
nal control. Primers used for human HPRT, FIH1, GLUT1, PHD3,
VEGF, CXCR4, TGFb1, and VHL are as follows: HPRT forward
50-GACCAGTCAACAGGGGACAT-30, HPRT reverse 50-AACACTTCG
TGGGGTCCTTTTC-30; FIH1 forward 50-TCATTGGCATGGAAGG
AAATGTG-30, FIH1 reverse 50-GGTAGAGGCACTCGAACTGA-30;
GLUT1 forward 50-ACCATTGGCTCCGGTATCG-30, GLUT1 reverse
50-GCTCGCTCCACCACAAACA-30; PHD3 forward 50-GGCCATCA
GCTTCCTCCTG-30, PHD3 reverse 50-GGTGATGCAGCGACCAT
CA-30; VEGF forward 50-ATGACGAGGGCCTGGAGTGTG-30,
VEGF reverse 50-CCTATGTGCTGGCCTTGGTGAG-30; CXCR4 for-
ward 50-ACCATGGAGGGGATCAGTATATACA-30, CXCR4 reverse
50-ACAGGGTTCCTTCATGGAGTCA-30; TGFb1 forward 50-TGAA
CCGGCCTTTCCTGCTTCTCATG-30, TGFb1 reverse 50-GCGGAAG
TCAATGTACAGCTGCCGC-30; and VHL forward 50-GTATGGCT
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Figure 6 | Effect of factor inhibiting hypoxia-inducible factor (HIF)-1 (FIH1) knockdown using FIH1 small interfering RNA (siRNA) in
human podocytes under ambient air and hypoxic conditions. (a) Immunoblots for HIF-1a, HIF-2a, FIH1, and HIF target genes, GLUT1
and prolyl hydroxylase domain (PHD)3. Overall, FIH1 knockdown efficacy was on average (normoxia and hypoxia) 63%. Luc, luciferase siRNA;
ctrl, control. (b) Fold induction of HIF target genes by hypoxia compared with levels under ambient conditions. Values are means±s.d. of
three independent experiments. *Po0.05 as compared with control. (c) Effect of FIH1 knockdown using FIH1 siRNA on mRNA expression of
the HIF-1a target genes, vascular endothelial growth factor (VEGF), GLUT1, PHD3, CXCR4, and transforming growth factor (TGF)b-1, as
determined by real-time PCR. Under 21% O2 (black bars), knockdown of FIH1 led to significant increases in mRNA expression of VEGF,
CXCR4, and TGFb-1, whereas no significant change in mRNA levels was detected for GLUT1 and PHD3. Under hypoxic conditions (16 h, 1%
oxygen, white bars), there was a further increase of PHD3 mRNA under conditions of FIH1 knockdown. FIH1 mRNA was downregulated by
FIH1 siRNA under both 21% O2 and 1% O2. Values are means±s.d. of three independent experiments and normalized to the corresponding
luciferase siRNA control. *Po0.05 as compared with luciferase siRNA treatment.
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CAACTTCGACGG-30, VHL reverse 50-GTGTGTCCCTGCATCTCT
GA-30. Primers used for rat HPRT, GLUT1, VEGFA, transgelin,
PHD3, TGFb1, CXCR4, and FIH1 are as follows: HPRT forward
50-CTCCTCAGACCGCTTTTCCC-30, HPRT reverse 50-ACCTGGTTC
ATCATCACTAATCACG-30; GLUT1 forward 50-GGTGTGCAGCAG
CCTGTGTA-30, GLUT1 reverse 50-GACGAACAGCGACACCACAG
T-30; VEGFA forward 50-CATAGGAGAGATGAGCTTCCTGC-30,
VEGFA reverse 50-CTCTGAACAAGGCTCACAGTGATTTTC-30; trans-
gelin forward 50-GAAAAGATATGGCAGCAGTG-30, transgelin
reverse 50-TTGACTGTCTGTGAACTCCC-30; PHD3 forward 50-GT
TCAGCCCTCCTATGC-30, PHD3 reverse 50-ACCACCGTCAGTC
TTTA-30; TGFb1 forward 50-TGCGCCTGCAGAGATTCAAGTCAA-30,
TGFb1 reverse 50-AAAGACAGCCACTCAGGCGTATCA-30; CXCR4
forward 50-GTGCAGCAGGTAGCAGTGAC-30, CXCR4 reverse 50-TC
CAGACCCTACTTCTTCGG-30; and FIH1 forward 50-TGCAGCAA
ACACTCAATGACACCG-30, FIH1 reverse 50-AGTGAGCAGGTG
TCACATTCCCTT-30. Primers used for mouse HPRT and FIH1:
HPRT forward 50-GTTGGATACAGGCCAGACTTTGT-30, HPRT
reverse 50-CCACAGGACTAGAACACCTGC-30; and FIH1 forward
50-GAAGATGGGCAATTTCCAGA-30, FIH1 reverse 50-CCACGGT
GTCATTGAGTGTC-30. Specificity and length of PCR products were
verified by melting point analyses and agarose gel electrophoresis,
respectively.
RNase protection assays were performed essentially as described
before.34 [32P]-labeled antisense RNA probes were transcribed with
SP6 or T7 polymerase (Roche, Mannheim, Germany) from
linearized plasmids containing complementary DNA fragments of
FIH1 and U6 small nuclear RNA. A quantity of 40 mg of total RNA
was hybridized to the radiolabeled probes and 1 mg total RNA to the
U6sn probe, which was used as an internal control for each sample.
Human kidney tissue
Nephrectomies were performed for suspected or proven renal
carcinomas. After microscopical evaluation by a nephropathologist,
tumor-free specimens of human kidneys were used for immuno-
histochemical analyses in accordance with the guidelines of the
clinical ethical committee.
Animals
Animal experiments were approved by the local institutional review
board for the care of animal subjects and were performed in
accordance with National Institutes of Health guidelines. Male
Sprague–Dawley rats (Charles River, Sulzfeld, Germany) were used
at weights of 200–230 g. C57BL/6 mice were purchased from Jackson
Laboratories, Sulzfeld, Germany. Animals were hosted in standard
cages, fed a standard diet and had free access to tap water. For
hypoxia experiments, animals were kept in 8% O2 or 0.1% CO,
respectively, for 6 h.
Animal model of anti-Thy1.1 nephritis
Male Sprague–Dawley rats (150–200 g) were obtained from Charles
River. Experimental mesangial proliferative glomerulonephritis (anti-
Thy.1 model) was induced by a single intravenous injection of anti-
Thy.1 antibodies into the tail vein (1 mg/kg body weight). The
monoclonal antibody OX-7 (European Collection of Animal Cell
Culture, Salisbury, UK) was kindly provided by Christian Hugo
(University Dresden, Germany). Urine samples of 24-h were collected
on days 2 and 3, 4 and 5, 7 and 8, and 11 and 12. Three animals for
each time point were killed on days 3, 5, 8, and 12, and kidneys were
obtained for further analysis. Control animals received isotonic saline
into the tail vein and kidneys were obtained on day 12 after injection.
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Figure 7 | Expression of factor inhibiting hypoxia-inducible factor-1 (FIH1) in experimental anti-Thy.1 nephritis. Animals (three rats
per time point) were injected with OX-7 antibody to induce anti-Thy.1 nephritis. (a) Proteinuria was significantly increased at all time
points examined. *Po0.05 as compared with control animals. (b) The time course of transgelin and CXCR4 mRNA expression in isolated
glomeruli (left) showed increased transcript abundance after 3 and 5 days, respectively. Transforming growth factor-b1 (TGFb1) mRNA
was increased throughout, whereas FIH1 and vascular endothelial growth factor A (VEGFA) were significantly decreased on day 3 (right).
(c) Immunohistochemistry for FIH1 on kidney sections from animals at different time points shows a decrease of FIH1 protein during
the course of anti-Thy.1 nephritis.
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Microdissection of nephron segments
Nephron segments were microdissected from rat kidneys essentially
as described previously.35 Fragments collected from the cortex were
glomeruli with (Gloþ ) and without arterioles (Glo), proximal
and distal convoluted tubules, cortical thick ascending limbs, and
connecting and cortical collecting ducts. From the outer medulla,
proximal straight tubules, descending thin limbs, medullary thick
ascending limbs, and outer medullary collecting ducts were isolated.
In the inner medulla, we collected descending/ascending thin limbs
of Henle and inner medullary collecting ducts. The segments were
identified by their morphological appearance, and classification was
confirmed with marker primers as shown in the study by Vitzthum
et al.36 RNA from the collected tubules was isolated as described
using standard procedures.37
Immunohistochemistry
Rodent kidneys were fixed by perfusion with 4% paraformaldehyde
in phosphate-buffered saline (pH 7.4) and processed for paraffin
embedding. Paraffin sections (2–4 mm) were dewaxed in xylene
and rehydrated in a series of ethanol washes. For detection of
HIF-1a and FIH1, a polyclonal rabbit anti-human HIF-1a antibody
(1:20,000, Cayman Chemicals, Ann Arbor, MI, USA), a polyclonal
rabbit anti-FIH1 antibody (1:10,000, NB100-428, Novus Biologi-
cals), or a goat anti-FIH1 antibody (1:10,000, N-18, Santa Cruz
Biotechnology) were used. For signal amplification of HIF-1a
and FIH1, a catalyzed signal amplification system (CSA-Kit,
Dako, Hamburg, Germany) was used as described previously.1 To
confirm specifity of the FIH1 staining, a blocking peptide for the
FIH1 antibody (NB100-428PEP, Novus Biologicals) was used.
Additional primary antibodies included: a rabbit anti-rat NaCl
cotransporter antibody (1:500, a kind gift from DJ Fife, Portland), a
sheep anti-rat b-hydroxysteroid dehydrogenase II (1:200, Chemicon
International, Temecula, CA, USA), a mouse anti-rat synaptopodin
(1:200, Progen, Heidelberg, Germany), a goat anti-Tamm–Horsfall
protein (1:500, THP, ICN, Aurora, OH, USA), a rabbit anti-rat
sodium phosphate cotransporter IIa (1:500, a kind gift from
J Biber and H Murer, Zu¨rich, Switzerland), an anti-CD31 (Dako),
a rabbit anti-ENACb (1:250, a kind gift from C Korbmacher,
Erlangen, Germany), a goat anti-human Aquaporin 2 (1:500,
Santa Cruz Biotechnology), and a mouse anti-rat endothelium
antibody (1:50, RECA-1, Serotec, Oxford, UK). Biotinylated or
fluorescence-labeled secondary antibodies (Dako) were employed
as applicable.
Immunoelectron microscopy
For postembedding immunogold labeling, specimens of normal rat
kidney were fixed in 4% paraformaldehyde and 0.1% glutaraldehyde
in 0.1 mol/l cacodylate buffer (pH 7.4) for 5 h at 4 1C. Specimens
were dehydrated serially to 70% ethanol at 20 1C and embedded in
resin (LR White; Electron Microscopy Sciences, Hatfield, PA, USA).
Ultrathin sections were successively incubated in Tris-buffered saline
(TBS), 0.05 mol/l glycine in TBS, 0.5% ovalbumin and 0.5% fish
gelatine in TBS, primary antibody diluted 1:10 in TBS-ovalbumin
overnight at 4 1C, and finally in 10 nm gold-conjugated secondary
antibody (BioCell, Cardiff, Wales, UK) diluted 1:30 in TBS-
ovalbumin for 1 h. After rinsing, the sections were stained with
uranyl acetate and examined with a transmission electron micro-
scope (906E, Carl Zeiss NTS GmbH, Oberkochen, Germany). In
negative control samples, the primary antibody was replaced by
phosphate-buffered saline or equimolar concentrations of nonim-
mune rabbit immunoglobulin G.
Statistics
All data given represent the means±s.d. A P-value o0.05 was
considered significant. Statistical analyses were performed using
Student’s t-test calculated with Sigma Stat-Software for Windows.
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